The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Wilson's Disease Market Research Report 2025
Synopsis
Wilson’s disease is also known as progressive lenticular degeneration and hepatolenticular degeneration that causes copper poisoning in the body. Copper is a necessary element for cellular functions; however, excessive copper is extremely toxic and can cause permanent damage to cellular functions of body. Wilson’s disease is caused by excessive deposition of copper in the body. Generally, copper is released into bile from the diet is cleaned out by the liver, flowing out of the body from the gastrointestinal tract. Wilson’s disease occurs due to excessive deposition of copper in the brain, liver, and other tissues of the body. According to the American Association for the Study of Liver Diseases, Wilson’s disease occurs worldwide with prevalence of approximately 30 individuals affected per million.
The global Wilson's Disease market was valued at US$ 204.1 million in 2023 and is anticipated to reach US$ 273.1 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
The classification of Wilson’s disease includes Trientine, Penicillamine and others, and the proportion of Trientine in 2019 is about 47%. Penicillamine was the first drug approved for the treatment of Wilson’s disease. Penicillamine is the most successful drug used for the treatment of Wilson’s disease. Wilson’s disease is widely used in Hospital, drugs stores and other field. The most proportion of Wilson’s disease is Drugs Store, and the proportion in 2019 is 51%. North America is the largest consumption place, with a consumption market share nearly 76.93% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 10.51%. Market competition is intense. Bausch Health, Teva, Endo International, Univar Solutions, MSN Laboratories, etc. are the leaders of the industry.
This report aims to provide a comprehensive presentation of the global market for Wilson's Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wilson's Disease.
Report Scope
The Wilson's Disease market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Wilson's Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Wilson's Disease companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bausch Health
Teva
Endo International
Univar Solutions
MSN Laboratories
ANI Pharmaceuticals
APOTEX
Tsumura
Sinepharm
Taj Pharmaceutical
Kadmon Holdings
Segment by Type
Trientine
Penicillamine
Others
Segment by Application
Hospital
Drugs Stores
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Wilson's Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Wilson’s disease is also known as progressive lenticular degeneration and hepatolenticular degeneration that causes copper poisoning in the body. Copper is a necessary element for cellular functions; however, excessive copper is extremely toxic and can cause permanent damage to cellular functions of body. Wilson’s disease is caused by excessive deposition of copper in the body. Generally, copper is released into bile from the diet is cleaned out by the liver, flowing out of the body from the gastrointestinal tract. Wilson’s disease occurs due to excessive deposition of copper in the brain, liver, and other tissues of the body. According to the American Association for the Study of Liver Diseases, Wilson’s disease occurs worldwide with prevalence of approximately 30 individuals affected per million.
The global Wilson's Disease market was valued at US$ 204.1 million in 2023 and is anticipated to reach US$ 273.1 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
The classification of Wilson’s disease includes Trientine, Penicillamine and others, and the proportion of Trientine in 2019 is about 47%. Penicillamine was the first drug approved for the treatment of Wilson’s disease. Penicillamine is the most successful drug used for the treatment of Wilson’s disease. Wilson’s disease is widely used in Hospital, drugs stores and other field. The most proportion of Wilson’s disease is Drugs Store, and the proportion in 2019 is 51%. North America is the largest consumption place, with a consumption market share nearly 76.93% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 10.51%. Market competition is intense. Bausch Health, Teva, Endo International, Univar Solutions, MSN Laboratories, etc. are the leaders of the industry.
This report aims to provide a comprehensive presentation of the global market for Wilson's Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wilson's Disease.
Report Scope
The Wilson's Disease market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Wilson's Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Wilson's Disease companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bausch Health
Teva
Endo International
Univar Solutions
MSN Laboratories
ANI Pharmaceuticals
APOTEX
Tsumura
Sinepharm
Taj Pharmaceutical
Kadmon Holdings
Segment by Type
Trientine
Penicillamine
Others
Segment by Application
Hospital
Drugs Stores
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Wilson's Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Wilson's Disease Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Trientine
1.2.3 Penicillamine
1.2.4 Others
1.3 Market by Application
1.3.1 Global Wilson's Disease Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Drugs Stores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Wilson's Disease Market Perspective (2019-2030)
2.2 Wilson's Disease Growth Trends by Region
2.2.1 Global Wilson's Disease Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Wilson's Disease Historic Market Size by Region (2019-2024)
2.2.3 Wilson's Disease Forecasted Market Size by Region (2025-2030)
2.3 Wilson's Disease Market Dynamics
2.3.1 Wilson's Disease Industry Trends
2.3.2 Wilson's Disease Market Drivers
2.3.3 Wilson's Disease Market Challenges
2.3.4 Wilson's Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Wilson's Disease Players by Revenue
3.1.1 Global Top Wilson's Disease Players by Revenue (2019-2024)
3.1.2 Global Wilson's Disease Revenue Market Share by Players (2019-2024)
3.2 Global Wilson's Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Wilson's Disease Revenue
3.4 Global Wilson's Disease Market Concentration Ratio
3.4.1 Global Wilson's Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Wilson's Disease Revenue in 2023
3.5 Wilson's Disease Key Players Head office and Area Served
3.6 Key Players Wilson's Disease Product Solution and Service
3.7 Date of Enter into Wilson's Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Wilson's Disease Breakdown Data by Type
4.1 Global Wilson's Disease Historic Market Size by Type (2019-2024)
4.2 Global Wilson's Disease Forecasted Market Size by Type (2025-2030)
5 Wilson's Disease Breakdown Data by Application
5.1 Global Wilson's Disease Historic Market Size by Application (2019-2024)
5.2 Global Wilson's Disease Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Wilson's Disease Market Size (2019-2030)
6.2 North America Wilson's Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Wilson's Disease Market Size by Country (2019-2024)
6.4 North America Wilson's Disease Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Wilson's Disease Market Size (2019-2030)
7.2 Europe Wilson's Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Wilson's Disease Market Size by Country (2019-2024)
7.4 Europe Wilson's Disease Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Wilson's Disease Market Size (2019-2030)
8.2 Asia-Pacific Wilson's Disease Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Wilson's Disease Market Size by Region (2019-2024)
8.4 Asia-Pacific Wilson's Disease Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Wilson's Disease Market Size (2019-2030)
9.2 Latin America Wilson's Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Wilson's Disease Market Size by Country (2019-2024)
9.4 Latin America Wilson's Disease Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Wilson's Disease Market Size (2019-2030)
10.2 Middle East & Africa Wilson's Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Wilson's Disease Market Size by Country (2019-2024)
10.4 Middle East & Africa Wilson's Disease Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bausch Health
11.1.1 Bausch Health Company Detail
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Wilson's Disease Introduction
11.1.4 Bausch Health Revenue in Wilson's Disease Business (2019-2024)
11.1.5 Bausch Health Recent Development
11.2 Teva
11.2.1 Teva Company Detail
11.2.2 Teva Business Overview
11.2.3 Teva Wilson's Disease Introduction
11.2.4 Teva Revenue in Wilson's Disease Business (2019-2024)
11.2.5 Teva Recent Development
11.3 Endo International
11.3.1 Endo International Company Detail
11.3.2 Endo International Business Overview
11.3.3 Endo International Wilson's Disease Introduction
11.3.4 Endo International Revenue in Wilson's Disease Business (2019-2024)
11.3.5 Endo International Recent Development
11.4 Univar Solutions
11.4.1 Univar Solutions Company Detail
11.4.2 Univar Solutions Business Overview
11.4.3 Univar Solutions Wilson's Disease Introduction
11.4.4 Univar Solutions Revenue in Wilson's Disease Business (2019-2024)
11.4.5 Univar Solutions Recent Development
11.5 MSN Laboratories
11.5.1 MSN Laboratories Company Detail
11.5.2 MSN Laboratories Business Overview
11.5.3 MSN Laboratories Wilson's Disease Introduction
11.5.4 MSN Laboratories Revenue in Wilson's Disease Business (2019-2024)
11.5.5 MSN Laboratories Recent Development
11.6 ANI Pharmaceuticals
11.6.1 ANI Pharmaceuticals Company Detail
11.6.2 ANI Pharmaceuticals Business Overview
11.6.3 ANI Pharmaceuticals Wilson's Disease Introduction
11.6.4 ANI Pharmaceuticals Revenue in Wilson's Disease Business (2019-2024)
11.6.5 ANI Pharmaceuticals Recent Development
11.7 APOTEX
11.7.1 APOTEX Company Detail
11.7.2 APOTEX Business Overview
11.7.3 APOTEX Wilson's Disease Introduction
11.7.4 APOTEX Revenue in Wilson's Disease Business (2019-2024)
11.7.5 APOTEX Recent Development
11.8 Tsumura
11.8.1 Tsumura Company Detail
11.8.2 Tsumura Business Overview
11.8.3 Tsumura Wilson's Disease Introduction
11.8.4 Tsumura Revenue in Wilson's Disease Business (2019-2024)
11.8.5 Tsumura Recent Development
11.9 Sinepharm
11.9.1 Sinepharm Company Detail
11.9.2 Sinepharm Business Overview
11.9.3 Sinepharm Wilson's Disease Introduction
11.9.4 Sinepharm Revenue in Wilson's Disease Business (2019-2024)
11.9.5 Sinepharm Recent Development
11.10 Taj Pharmaceutical
11.10.1 Taj Pharmaceutical Company Detail
11.10.2 Taj Pharmaceutical Business Overview
11.10.3 Taj Pharmaceutical Wilson's Disease Introduction
11.10.4 Taj Pharmaceutical Revenue in Wilson's Disease Business (2019-2024)
11.10.5 Taj Pharmaceutical Recent Development
11.11 Kadmon Holdings
11.11.1 Kadmon Holdings Company Detail
11.11.2 Kadmon Holdings Business Overview
11.11.3 Kadmon Holdings Wilson's Disease Introduction
11.11.4 Kadmon Holdings Revenue in Wilson's Disease Business (2019-2024)
11.11.5 Kadmon Holdings Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Wilson's Disease Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Trientine
Table 3. Key Players of Penicillamine
Table 4. Key Players of Others
Table 5. Global Wilson's Disease Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Wilson's Disease Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Wilson's Disease Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Wilson's Disease Market Share by Region (2019-2024)
Table 9. Global Wilson's Disease Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Wilson's Disease Market Share by Region (2025-2030)
Table 11. Wilson's Disease Market Trends
Table 12. Wilson's Disease Market Drivers
Table 13. Wilson's Disease Market Challenges
Table 14. Wilson's Disease Market Restraints
Table 15. Global Wilson's Disease Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Wilson's Disease Market Share by Players (2019-2024)
Table 17. Global Top Wilson's Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Wilson's Disease as of 2023)
Table 18. Ranking of Global Top Wilson's Disease Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Wilson's Disease Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Wilson's Disease Product Solution and Service
Table 22. Date of Enter into Wilson's Disease Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Wilson's Disease Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Wilson's Disease Revenue Market Share by Type (2019-2024)
Table 26. Global Wilson's Disease Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Wilson's Disease Revenue Market Share by Type (2025-2030)
Table 28. Global Wilson's Disease Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Wilson's Disease Revenue Market Share by Application (2019-2024)
Table 30. Global Wilson's Disease Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Wilson's Disease Revenue Market Share by Application (2025-2030)
Table 32. North America Wilson's Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Wilson's Disease Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Wilson's Disease Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Wilson's Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Wilson's Disease Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Wilson's Disease Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Wilson's Disease Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Wilson's Disease Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Wilson's Disease Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Wilson's Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Wilson's Disease Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Wilson's Disease Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Wilson's Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Wilson's Disease Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Wilson's Disease Market Size by Country (2025-2030) & (US$ Million)
Table 47. Bausch Health Company Detail
Table 48. Bausch Health Business Overview
Table 49. Bausch Health Wilson's Disease Product
Table 50. Bausch Health Revenue in Wilson's Disease Business (2019-2024) & (US$ Million)
Table 51. Bausch Health Recent Development
Table 52. Teva Company Detail
Table 53. Teva Business Overview
Table 54. Teva Wilson's Disease Product
Table 55. Teva Revenue in Wilson's Disease Business (2019-2024) & (US$ Million)
Table 56. Teva Recent Development
Table 57. Endo International Company Detail
Table 58. Endo International Business Overview
Table 59. Endo International Wilson's Disease Product
Table 60. Endo International Revenue in Wilson's Disease Business (2019-2024) & (US$ Million)
Table 61. Endo International Recent Development
Table 62. Univar Solutions Company Detail
Table 63. Univar Solutions Business Overview
Table 64. Univar Solutions Wilson's Disease Product
Table 65. Univar Solutions Revenue in Wilson's Disease Business (2019-2024) & (US$ Million)
Table 66. Univar Solutions Recent Development
Table 67. MSN Laboratories Company Detail
Table 68. MSN Laboratories Business Overview
Table 69. MSN Laboratories Wilson's Disease Product
Table 70. MSN Laboratories Revenue in Wilson's Disease Business (2019-2024) & (US$ Million)
Table 71. MSN Laboratories Recent Development
Table 72. ANI Pharmaceuticals Company Detail
Table 73. ANI Pharmaceuticals Business Overview
Table 74. ANI Pharmaceuticals Wilson's Disease Product
Table 75. ANI Pharmaceuticals Revenue in Wilson's Disease Business (2019-2024) & (US$ Million)
Table 76. ANI Pharmaceuticals Recent Development
Table 77. APOTEX Company Detail
Table 78. APOTEX Business Overview
Table 79. APOTEX Wilson's Disease Product
Table 80. APOTEX Revenue in Wilson's Disease Business (2019-2024) & (US$ Million)
Table 81. APOTEX Recent Development
Table 82. Tsumura Company Detail
Table 83. Tsumura Business Overview
Table 84. Tsumura Wilson's Disease Product
Table 85. Tsumura Revenue in Wilson's Disease Business (2019-2024) & (US$ Million)
Table 86. Tsumura Recent Development
Table 87. Sinepharm Company Detail
Table 88. Sinepharm Business Overview
Table 89. Sinepharm Wilson's Disease Product
Table 90. Sinepharm Revenue in Wilson's Disease Business (2019-2024) & (US$ Million)
Table 91. Sinepharm Recent Development
Table 92. Taj Pharmaceutical Company Detail
Table 93. Taj Pharmaceutical Business Overview
Table 94. Taj Pharmaceutical Wilson's Disease Product
Table 95. Taj Pharmaceutical Revenue in Wilson's Disease Business (2019-2024) & (US$ Million)
Table 96. Taj Pharmaceutical Recent Development
Table 97. Kadmon Holdings Company Detail
Table 98. Kadmon Holdings Business Overview
Table 99. Kadmon Holdings Wilson's Disease Product
Table 100. Kadmon Holdings Revenue in Wilson's Disease Business (2019-2024) & (US$ Million)
Table 101. Kadmon Holdings Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Wilson's Disease Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Wilson's Disease Market Share by Type: 2023 VS 2030
Figure 3. Trientine Features
Figure 4. Penicillamine Features
Figure 5. Others Features
Figure 6. Global Wilson's Disease Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Wilson's Disease Market Share by Application: 2023 VS 2030
Figure 8. Hospital Case Studies
Figure 9. Drugs Stores Case Studies
Figure 10. Others Case Studies
Figure 11. Wilson's Disease Report Years Considered
Figure 12. Global Wilson's Disease Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Wilson's Disease Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Wilson's Disease Market Share by Region: 2023 VS 2030
Figure 15. Global Wilson's Disease Market Share by Players in 2023
Figure 16. Global Top Wilson's Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Wilson's Disease as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Wilson's Disease Revenue in 2023
Figure 18. North America Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Wilson's Disease Market Share by Country (2019-2030)
Figure 20. United States Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Wilson's Disease Market Share by Country (2019-2030)
Figure 24. Germany Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Wilson's Disease Market Share by Region (2019-2030)
Figure 32. China Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Wilson's Disease Market Share by Country (2019-2030)
Figure 40. Mexico Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Wilson's Disease Market Share by Country (2019-2030)
Figure 44. Turkey Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Wilson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Bausch Health Revenue Growth Rate in Wilson's Disease Business (2019-2024)
Figure 47. Teva Revenue Growth Rate in Wilson's Disease Business (2019-2024)
Figure 48. Endo International Revenue Growth Rate in Wilson's Disease Business (2019-2024)
Figure 49. Univar Solutions Revenue Growth Rate in Wilson's Disease Business (2019-2024)
Figure 50. MSN Laboratories Revenue Growth Rate in Wilson's Disease Business (2019-2024)
Figure 51. ANI Pharmaceuticals Revenue Growth Rate in Wilson's Disease Business (2019-2024)
Figure 52. APOTEX Revenue Growth Rate in Wilson's Disease Business (2019-2024)
Figure 53. Tsumura Revenue Growth Rate in Wilson's Disease Business (2019-2024)
Figure 54. Sinepharm Revenue Growth Rate in Wilson's Disease Business (2019-2024)
Figure 55. Taj Pharmaceutical Revenue Growth Rate in Wilson's Disease Business (2019-2024)
Figure 56. Kadmon Holdings Revenue Growth Rate in Wilson's Disease Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
